Managing Suicide Risk in Patients with Schizophrenia
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The management of suicide risk in patients with schizophrenia poses many challenges for clinicians. Compared with the general population, these patients have an 8.5-fold greater risk of suicide. This article reviews the literature dealing with the treatment of at-risk patients with schizophrenia. An integrated psychosocial and pharmacological approach to managing this population of patients is recommended. Although there is at least modest evidence suggesting that antipsychotic medications protect against suicidal risk, the evidence appears to be most favourable for second-generation anti-psychotics, particularly clozapine, which is the only medication approved by the US FDA for preventing suicide in patients with schizophrenia. In addition, treating depressive symptoms in patients with schizophrenia is an important component of suicide risk reduction. While selective serotonin receptor inhibitors (SSRIs) ameliorate depressive symptoms in patients with schizophrenia, they also appear to attenuate suicidal thoughts. Further research is needed to more effectively personalize the treatment of suicidal thoughts and behaviours and the prevention of suicide in patients with schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589 · cited 2×
“Much of the literature has suggested that 9–13% of patients with schizophrenia have completed suicide.([4,9,10]) However, in a recent review of the literature on suicide and schizophrenia, Palmer et al.”
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.559 · Cited by 1,723
Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.1 · Cited by 1,428
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393 · cited 7×
“The panel was blinded to treatment group assignment.([95]) Improved outcomes were observed with clozapine compared with olanzapine (figure 1).”
InfluentialTiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
The Lifetime Risk of Suicide in Schizophrenia: A Reexamination
Palmer, B. A., Pankratz, V. S., & Bostwick, J. M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.247 · Cited by 1,026 · cited 3×
“Individuals with schizophrenia who attempt suicide appear to be more impulsive.([11,13]) The treatment of patients with schizophrenia and suicidal behaviour is challenging.”
Influential(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1001 · Cited by 725 · cited 1×
“The connection between suicide, schizophrenia and substance abuse is also important.([27,32,33]) Substance abuse and alcoholism can worsen impulsiveness as well as social isolation.”
Breier, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270051007 · Cited by 626
CONDITIONS PREDISPOSING TO SUICIDE: A REVIEW
MILES, C. P. (1977) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197704000-00002 · Cited by 504
Suicide within 12 months of contact with mental health services: national clinical survey
Appleby, L., Shaw, J., Amos, T., McDonnell, R., Harris, C., McCann, K., Kiernan, K., Davies, S., Bickley, H., & Parsons, R. (1999) · BMJ · doi:10.1136/bmj.318.7193.1235 · Cited by 469 · cited 1×
“Enhancing adherence to psychiatric followup and maintenance of social support are important components of caring for this group of patients.([70,71]) In addition, maintaining adherence to antipsychotic drug treatment is a critical component of the treatment of patients with schizophrenia in general.”
Cited by
Suicide risk assessment and intervention in people with mental illness
Bolton, J. M., Gunnell, D., & Turecki, G. (2015) · BMJ · doi:10.1136/bmj.h4978 · Cited by 294
Clozapine: a review of clinical practice guidelines and prescribing trends
Warnez, S., & Alessi-Severini, S. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-102 · Cited by 234
Taipale, H., Lähteenvuo, M., Tanskanen, A., Mittendorfer-Rutz, E., & Tiihonen, J. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa111 · Cited by 85
Hswen, Y., Naslund, J. A., Brownstein, J. S., & Hawkins, J. B. (2018) · JMIR Mental Health · doi:10.2196/11483 · Cited by 43
The Role of Social Isolation in the Relationships between Psychosis and Suicidal Ideation
Bornheimer, L. A., Li, J., Im, V., Taylor, M., & Himle, J. A. (2020) · Clinical Social Work Journal · doi:10.1007/s10615-019-00735-x · Cited by 40
Metadata
- Authors
- Kasckow, J., Felmet, K., & Zisook, S.
- Venue
- CNS Drugs
- Published
- 2011-02
- Volume
- 25
- Issue
- 2
- Pages
- 129-143
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W1967857831
- Cited by
- 133
- References
- 17
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Managing Suicide Risk in Patients with Schizophrenia. https://app.cochat.ai/papers/10.2165/11586450-000000000-00000
- The paper
- Kasckow, J., Felmet, K., & Zisook, S. (2011). Managing Suicide Risk in Patients with Schizophrenia. CNS Drugs. https://doi.org/10.2165/11586450-000000000-00000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.